We are presenting our data at the DDR inhibitor summit, January 24 – 26, 2023, Boston, US
We are excited to hear about the newest progress in the DDR field and look forward to all interesting
discussions.
One-carbon Therapeutics to Present Trial-in-Progress Poster on ODIN Phase 1/2 Study ofTH9619 at the 2026 ASCO Annual Meeting
Solna, Sweden, May 29th, 2026. One-carbon Therapeutics AB, a clinical-stage
